RBL Bank reported a strong March quarter performance on Saturday, April 25, with net profit surging 234% year-on-year to ₹230 crore, as improved asset quality. Net interest income (NII) rose 7% YoY and 1% sequentially to ₹1,671 crore, while net interest margin (NIM) stood at 4.41%. Other income grew 7% YoY to ₹1,069 crore, supported…
Shares of Union Bank of India Ltd. extended their losses for the second day on Friday, April 24, declining over 2%, as they continued to react to their fourth quarter earnings. The stock has now declined 10% over the last two sessions, following a 7.5% drop on Thursday after the results were reported. Brokerages have…
Shares of Fortis Healthcare Ltd. are in focus on Friday, April 24, after brokerage Motilal Oswal Financial Services initiated coverage on the stock with a ‘Buy’ rating. The brokerage has a target price of ₹1,100, implying an upside of around 19% from the previous close. In its bull case scenario, it sees the stock rising…
Axis Bank reported an operating profit of Rs 10,013 crore for the quarter, while core operating profit came in at Rs 10,619 crore, according to its regulatory filing. Operating expenses rose 6 per cent year-on-year in Q4FY26. Meanwhile, profit after tax (PAT) increased 9 per cent sequentially from Rs 6,490 crore in Q3FY26. Source link
April 28, 2026: Bandhan Bank, Canara HSBC Life Insurance Company, Castrol India, CEAT, Dhanlaxmi Bank, Emmvee Photovoltaic Power, Eternal, Go Digit General Insurance, Garden Reach Shipbuilders & Engineers, Mahindra Lifespace Developers, Maruti Suzuki India, Sanofi India, Sanofi Consumer Healthcare India, Star Health and Allied Insurance Company, Leela Palaces Hotels & Resorts. Source link
Alembic Pharmaceuticals Ltd. has received final approval from the US Food and Drug Administration (USFDA) for its Fingolimod Capsules, 0.5 mg, the company announced on Saturday, April 25. The approval is for the company’s Abbreviated New Drug Application (ANDA), with the product being therapeutically equivalent to Novartis’ reference listed drug, Gilenya Capsules, 0.5 mg. Fingolimod…
Shares of SBI Life Insurance declined from the day’s high on Friday (April 24) after comments by Union Finance Minister Nirmala Sitharaman raised the possibility of changes in insurance distribution norms. The stock opened at ₹1,829.95 on the BSE, touched an intraday high of ₹1,836, and fell to a low of ₹1,772.90 during the session,…
The Reserve Bank of India (RBI) has revoked the banking licence of Paytm Payments Bank Limited, effectively bringing its operations as a bank to an end. The decision came into effect from the close of business on April 24, 2026, under Section 22(4) of the Banking Regulation Act, 1949. The central bank stated that the…
Gautam Shah, Founder, Goldilocks Global Research, expects the Nifty to remain range-bound between 23,500 and 24,600, signalling a consolidation phase after the recent rally. “We go back to normal business,” Shah said, adding that earnings, consumption trends, artificial intelligence (AI) disruption and continued foreign institutional investors (FII) selling will drive markets from here. He also…
The Indian IT sector is entering a tougher phase, with slowing growth and structural disruption from artificial intelligence (AI) likely to keep returns muted. Bhavin Shah, Founder, CIO & CEO of Sameeksha Capital, believes investors should stay cautious as expectations reset lower. “It is certainly disappointing, although not unexpected. Outlook for the sector, if you…
